Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
construction
Biotech
AstraZeneca keeps UK research site on pause, but options open
AZ is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its hometown, despite keeping its options open.
James Waldron
Jan 26, 2026 9:25am
Berkeley incubator plots new building for expanding biotechs
Jul 21, 2025 8:00am
Roche ramps up R&D with new high-rise labs
Sep 11, 2024 10:40am
Selvita's growth continues with completion of new Krakow HQ
Mar 29, 2023 3:35pm
Novo Nordisk recruits, lays off staff in Boston expansion
Mar 2, 2023 9:25am